The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 13 of the 20 sources its claims cite were checked for support.
Rapid and Robust Generation of Homozygous Fluorescent Reporter Knock-In Cell Pools by CRISPR-Cas9
Open accessAbstract
Conventional methods for generating knock-out or knock-in mammalian cell models using CRISPR-Cas9 genome editing often require tedious single-cell clone selection and expansion. In this study, we develop and optimise rapid and robust strategies to engineer homozygous fluorescent reporter knock-in cell pools with precise genome editing, circumventing clonal variability inherent to traditional approaches. To reduce false-positive cells associated with random integration, we optimise the design of donor DNA by removing the start codon of the fluorescent reporter and incorporating a self-cleaving T2A peptide system. Using fluorescence-assisted cell sorting (FACS), we efficiently identify and isolate the desired homozygous fluorescent knock-in clones, establishing stable cell pools that preserve parental cell line heterogeneity and faithfully reflect endogenous transcriptional regulation of the target gene. We evaluate the knock-in efficiency and rate of undesired random integration in the electroporation method with either a dual-plasmid system (sgRNA and donor DNA in two separate vectors) or a single-plasmid system (sgRNA and donor DNA combined in one vector). We further demonstrate that coupling our single-plasmid construct with an integrase-deficient lentivirus vector (IDLV) packaging system efficiently generates fluorescent knock-in reporter cell pools, offering flexibility between electroporation and lentivirus transduction methods. Notably, compared to the electroporation methods, the IDLV system significantly minimises random integration. Moreover, the resulting reporter cell lines are compatible with most of the available genome-wide sgRNA libraries, enabling unbiased CRISPR screens to identify key transcriptional regulators of a gene of interest. Overall, our methodologies provide a powerful genetic tool for rapid and robust generation of fluorescent reporter knock-in cell pools with precise genome editing by CRISPR-Cas9 for various research purposes.
Overview
CoChat Summary
TL;DR
The paper develops and compares dual-plasmid, single-plasmid, and integrase-deficient lentiviral vector (IDLV) CRISPR-Cas9 strategies to generate homozygous fluorescent reporter knock-in cell pools without single-cell cloning. IDLV combined with FACS sorting of GFPhigh/miRFP670− cells minimizes random integration while maintaining editing efficiency, and the resulting TSPAN8 reporter line supports genome-wide CRISPR screens.
Key findings
- Dual-plasmid electroporation yielded maximum GFP+ efficiency of ~4% at 10 and 20 µg plasmid per million MEC cells; single-plasmid electroporation peaked at ~3.8% with 20 µg, slightly below the dual-plasmid system (4.5%).
- FACS enrichment of the top ~5% GFPhigh cells produced homozygous TSPAN8-T2A-GFP reporter pools; PCR genotyping detected only the knock-in band in final pools, and ~75% of single-cell clones likely harbored homozygous KI/KI alleles.
- IDLV at 4X achieved integration efficiency comparable to the maximum single-plasmid electroporation result, with no further improvement at 6X; random integration was undetectable in homozygous GFP reporter KI pools at 4X IDLV. ddPCR GFP:TSPAN8 copy-number ratios were 1.8 for dual-plasmid, 1.2 for single-plasmid, and near 1:1 for IDLV.
- A genome-wide CRISPR-Cas9 screen using ~200,000 sgRNAs (10 per gene) on ~300 million reporter cells identified NF2, DYRK1A, and SOX9 as regulators of TSPAN8; SOX9 was validated by FACS and qPCR and in SNU878 cells.
Methods
- Cell lines: MEC and JHH5 liver cancer cells stably expressing Cas9 were used for TSPAN8 reporter generation; SNU878 was used for validation. Donor DNA used a T2A-GFP/eGFP cassette with the fluorescent reporter start codon removed and ~800 bp homology arms.
- Three delivery strategies were compared: dual-plasmid electroporation (separate sgRNA and donor vectors), single-plasmid electroporation (combined sgRNA and donor DNA with miRFP670 marker), and IDLV packaging using pBK43 (D64E). Validation included FACS, PCR genotyping, Sanger sequencing, Western blot, long-range PCR, and ddPCR.
- Genome-wide CRISPR-Cas9 knockout screening used the Sabatini/Lander library at MOI 0.3–0.5, puromycin selection, FACS sorting for GFPlow cells, NGS, and MAGeCK analysis.
Limitations
- Stated: the approaches rely on FACS of a fluorescent reporter driven by the endogenous promoter, so they are not suitable for non-fluorescent reporters such as LacZ, luciferases, or other enzymes; they require target gene expression to be detectable and sufficiently uniform and are not feasible for genes silent in parent cells.
- Stated: the study does not address CRISPR-Cas9 off-target effects, and its dependence on HDR may limit generalizability in cell types or cell-cycle states with low HDR activity, such as cells with BRCA1 defects.
- Evident from the text: electroporation approaches still showed random donor plasmid integration by PCR and elevated GFP:TSPAN8 ddPCR ratios (1.8 dual, 1.2 single), although IDLV minimized this; no direct off-target sequencing is reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
10 Valid · 3 Not valid · 4 Not checked · 84 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, CRISPR-Cas9-mediated HDR frequently results in monoallelic knock-ins, where only one allele is precisely modified while the other remains unedited or acquires variable indels [5].”
§ Rapid and Robust Generation of Homozygous Fluorescent Reporter Knock-In Cell Pools by CRISPR-Cas9 > 1. Introduction
What the sources say
- Partly supportedcites [5] Leal, A.F., Herreno-Pachon, A.M., Benincore-Florez, E., Karunathilaka, A., and Tomatsu, S. (2024). Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches. Int. J. Mol. Sci., 25. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says genome editing in human cells mainly produces monoallelic modifications, with the second copy unaltered or undesirably modified. It also identifies indels as a possible consequence of Cas9-mediated repair. The citing sentence presents this as a frequent outcome of CRISPR-Cas9-mediated HDR without the source’s human-cell qualifier. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We then conducted two rounds of FACS, separated by 6 days of cell culture, to enrich the top ~5% GFPhigh cells and establish TSPAN8 KO reporter JHH5 and MEC cell lines, which exhibited complete loss of TSPAN8 expression, confirmed by FACS (Figure 2D) and Western blot (Figure 2E) analyses.”
§ Rapid and Robust Generation of Homozygous Fluorescent Reporter Knock-In Cell Pools by CRISPR-Cas9 > 3. Results > 3.1. FACS Is an Efficient Way to Enrich Biallelically Engineered Knock-In Reporter Cells
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Genotypic analysis of these clones revealed that ~75% of them most likely harboured homozygous knock-in (KI/KI) alleles (Figure S2B).”
§ Rapid and Robust Generation of Homozygous Fluorescent Reporter Knock-In Cell Pools by CRISPR-Cas9 > 3. Results > 3.2. Generation of Homozygous Fluorescent Knock-In Reporter Cell Pools Using a Dual-Plasmid System
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“FACS analysis confirmed that the endogenous expression of TSPAN8 protein remains intact in these cells (Figure 3C).”
§ Rapid and Robust Generation of Homozygous Fluorescent Reporter Knock-In Cell Pools by CRISPR-Cas9 > 3. Results > 3.2. Generation of Homozygous Fluorescent Knock-In Reporter Cell Pools Using a Dual-Plasmid System
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Flow cytometry analysis showed KI/KI clones expressed higher levels of GFP compared to heterozygous (KI/+) (Figure S2B).”
§ Rapid and Robust Generation of Homozygous Fluorescent Reporter Knock-In Cell Pools by CRISPR-Cas9 > 3. Results > 3.2. Generation of Homozygous Fluorescent Knock-In Reporter Cell Pools Using a Dual-Plasmid System
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
45 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 17
- It may state two separate claims as one. 35
- The quote only partly states this claim. 2
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572 · cited 1×
“PCR amplification using primers flanking the target region, followed by Sanger sequencing, is commonly employed to detect the correct integration of the tag into the target locus [16,26,27].”
Li, W., Xu, H., Xiao, T., Cong, L., Love, M. I., Zhang, F., Irizarry, R. A., Liu, J. S., Brown, M., & Liu, X. S. (2014) · Genome Biology · doi:10.1186/s13059-014-0554-4 · Cited by 2,684 · cited 1×
“Data normalisation and sgRNA modelling and ranking were performed by using the MAGeCK algorithm as previously described [15].”
Identification and characterization of essential genes in the human genome
Wang, T., Birsoy, K., Hughes, N. W., Krupczak, K. M., Post, Y., Wei, J. J., Lander, E. S., & Sabatini, D. M. (2015) · Science · doi:10.1126/science.aac7041 · Cited by 1,617
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
Lin, S., Staahl, B. T., Alla, R. K., & Doudna, J. A. (2014) · eLife · doi:10.7554/elife.04766 · Cited by 1,189 · cited 1×
“Such accuracy in homology recombination is critical for precise genome engineering [4].”
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Dever, D. P., Bak, R. O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C. E., Pavel-Dinu, M., Saxena, N., Wilkens, A. B., Mantri, S., et al. (2016) · Nature · doi:10.1038/nature20134 · Cited by 864 · cited 1×
“This delivery method remains challenging to use for many cell types and often requires large amounts of DNA, which can compromise cell viability and lead to substantial random integration [6].”
DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing
Xue, C., & Greene, E. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.02.008 · Cited by 431 · cited 1×
“The Cas9 endonuclease induces site-specific double-strand breaks (DSBs) guided by single-guide RNAs (sgRNAs), which direct Cas9 to predefined genomic loci [2].”
Xu, Y., & Li, Z. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.031 · Cited by 404 · cited 1×
“Gene-editing tools such as zinc-finger nucleases, TALENs (transcription activator-like effector nucleases), and the more recent CRISPR-Cas9 system hold significant promise for advancing gene therapy [1].”
Aubrey, B. J., Kelly, G. L., Kueh, A. J., Brennan, M. S., O’Connor, L., Milla, L., Wilcox, S., Tai, L., Strasser, A., & Herold, M. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.002 · Cited by 399 · cited 1×
“To generate sgRNA plasmids for CRISPR/Cas9 genome editing, the doxycycline-inducible sgRNA vector system Fgh1tUT (Addgene, Watertown, MA, USA, Plasmid #70183) was utilised [12].”
Self-citationSeki, A., & Rutz, S. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171626 · Cited by 372 · cited 1×
“One effective method involves electroporating Cas9 ribonucleoprotein (RNP) complexes along with donor plasmids, which has demonstrated high editing efficiency [30].”
Integration of DNA into bacterial chromosomes from plasmids without a counter-selection marker
Heap, J. T., Ehsaan, M., Cooksley, C. M., Ng, Y.-K., Cartman, S. T., Winzer, K., & Minton, N. P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1321 · Cited by 201 · cited 1×
“We used the FgH1tUT vectors, which enable the sgRNA expression under the control of doxycycline and harbour the miRFP670 fluorescent reporter driven by the Ubiquitin promoter [21] (Figure 1B).”
VDAC2 enables BAX to mediate apoptosis and limit tumor development
Chin, H. S., Li, M. X., Tan, I. K. L., Ninnis, R. L., Reljic, B., Scicluna, K., Dagley, L. F., Sandow, J. J., Kelly, G. L., Samson, A. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07309-4 · Cited by 196 · cited 1×
“Pilot experiments were performed to determine the virus input required to achieve MOI = 0.3–0.5, corresponding to around 70% and 50% cell death upon puromycin selection, respectively, as previously described [14].”
InfluentialSelf-citationCampbell, B. C., Nabel, E. M., Murdock, M. H., Lao-Peregrin, C., Tsoulfas, P., Blackmore, M. G., Lee, F. S., Liston, C., Morishita, H., & Petsko, G. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000942117 · Cited by 170 · cited 1×
“The donor DNA, cloned into the pUC57 vector, contains the T2A-GFP [22] cassette flanked by 5 ′ and 3 ′ homology arms (~800 bp) at both sides.”
Ortinski, P. I., O’Donovan, B., Dong, X., & Kantor, B. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.04.002 · Cited by 146 · cited 1×
“To generate IDLV lentivirus, the packaging plasmid pMDLg/pRRE was replaced with the pBK43 (D64E) plasmid, which disables the integration function of lentiviral vectors while maintaining their ability to efficiently deliver genetic materials into infected cells [28].”
Generation and validation of homozygous fluorescent knock-in cells using CRISPR-Cas9 genome editing
Koch, B., Nijmeijer, B., Kueblbeck, M., Cai, Y., Walther, N., & Ellenberg, J. (2018) · Nature Protocols · doi:10.1038/nprot.2018.042 · Cited by 134 · cited 2×
“To integrate a fluorescent reporter into the genome by CRISPR-Cas9 genome editing, we first tested a dual-plasmid system, as commonly employed in previous studies [16–20].”
Detection of Deleterious On-Target Effects after HDR-Mediated CRISPR Editing
Weisheit, I., Kroeger, J. A., Malik, R., Klimmt, J., Crusius, D., Dannert, A., Dichgans, M., & Paquet, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107689 · Cited by 125 · cited 1×
“Mammalian cells respond to DSBs by activating two key repair pathways: non-homologous end joining (NHEJ) and homology-directed repair (HDR) [3].”
Overcoming the Specific Toxicity of Large Plasmids Electrotransfer in Primary Cells In Vitro
Lesueur, L. L., Mir, L. M., & André, F. M. (2016) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2016.4 · Cited by 118 · cited 1×
“These findings align with previous studies showing that overly high plasmid concentrations can lead to cellular toxicity, reduced transfection efficiency, or activation of cellular stress responses to impair HDR efficiency [20,25].”
High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA
Oh, S. A., Senger, K., Madireddi, S., Akhmetzyanova, I., Ishizuka, I. E., Tarighat, S., Lo, J. H., Shaw, D., Haley, B., & Rutz, S. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20211530 · Cited by 88 · cited 2×
“To integrate a fluorescent reporter into the genome by CRISPR-Cas9 genome editing, we first tested a dual-plasmid system, as commonly employed in previous studies [16–20].”
Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches
Leal, A., Herreno-Pachón, A., Benincore-Flórez, E., Karunathilaka, A., & Tomatsu, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052456 · Cited by 58 · cited 1×
“However, CRISPR-Cas9-mediated HDR frequently results in monoallelic knock-ins, where only one allele is precisely modified while the other remains unedited or acquires variable indels [5].”
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Uchida, N., Drysdale, C. M., Nassehi, T., Gamer, J., Yapundich, M., DiNicola, J., Shibata, Y., Hinds, M., Gudmundsdottir, B., Haro-Mora, J. J., et al. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.02.022 · Cited by 55 · cited 1×
“This system enables transient delivery of sgRNA and donor DNA without genomic integration, minimising off-target and random risks while bypassing the need for electroporation [9,10].”
SOX9 is a critical regulator of TSPAN8-mediated metastasis in pancreatic cancer
Li, J., Chen, X., Zhu, L., Lao, Z., Zhou, T., Zang, L., Ge, W., Jiang, M., Xu, J., Cao, Y., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01864-9 · Cited by 45 · cited 1×
“Notably, SOX9 has been previously identified as a transcription factor regulating TSPAN8 [29], further supporting the robustness of our approach.”
Supharattanasitthi, W., Carlsson, E., Sharif, U., & Paraoan, L. (2019) · Scientific Reports · doi:10.1038/s41598-018-36740-2 · Cited by 32
Wang, Y., Wang, Y., Chang, T., Huang, H., & Yee, J.-K. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1057 · Cited by 26 · cited 1×
“This system enables transient delivery of sgRNA and donor DNA without genomic integration, minimising off-target and random risks while bypassing the need for electroporation [9,10].”
Yang, J., Guo, F., Chin, H. S., Chen, G. B., Ang, C. H., Lin, Q., Hong, W., & Fu, N. Y. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112065 · Cited by 22 · cited 3×
“In the third-generation integration-competent lentivirus vector (ICLV) system [23], lentivirus particles are produced using three packaging plasmids: pM2D.”
Self-citationProtocol for the Generation of Human Pluripotent Reporter Cell Lines Using CRISPR/Cas9
Zhong, A., Li, M., & Zhou, T. (2020) · STAR Protocols · doi:10.1016/j.xpro.2020.100052 · Cited by 21
Vijayraghavan, S., & Kantor, B. (2017) · Journal of Visualized Experiments · doi:10.3791/56915 · Cited by 20 · cited 1×
“However, conventional lentiviral systems integrate into the host genome, posing risks of insertional mutagenesis and limiting their clinical applicability [8].”
Pi, W., Feng, G., Liu, M., Nie, C., Chen, C., Wang, J., Wang, L., Wan, P., Liu, C., Zhou, P., et al. (2024) · doi:10.20944/preprints202407.1610.v1 · Cited by 16
Pi, W., Feng, G., Liu, M., Nie, C., Chen, C., Wang, J., Wang, L., Wan, P., Liu, C., Zhou, P., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179145 · Cited by 16 · cited 1×
“In addition to this approach, electroporation of pre-assembled CRISPR-Cas9 ribonucleoprotein (RNP) complexes together with donor DNA has emerged as an effective alternative [7].”
(1990) · PubMed · Cited by 11
Molecular Regulation and Oncogenic Functions of TSPAN8
Yang, J., Zhang, Z., Lam, J. S. W., Fan, H., & Fu, N. Y. (2024) · Cells · doi:10.3390/cells13020193 · Cited by 11 · cited 1×
“We selected TSPAN8 , a gene encoding a cell-surface protein [23,24], as a representative example for our studies.”
Self-citationCRISPR/Cas9 + AAV-mediated Intra-embryonic Gene Knocking in Mice
Mizuno, N., Mizutani, E., Sato, H., Kasai, M., Nakauchi, H., & Yamaguchi, T. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3295 · Cited by 8
Rapid clonal identification of biallelic CRISPR/Cas9 knock-ins using SNEAK PEEC
Singh, S. K., Banerjee, A., Broeck, A. V., & Klinge, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-28732-8 · Cited by 6
Heller (2001) · doi:10.1002/1522-2683(200102)22:4<629::aid-elps629>3.0.co;2-s
Cited by
Viral genome editing methods and applications in the CRISPR era
Shin, K., & Kim, E. T. (2026) · Journal of Virology · doi:10.1128/jvi.02048-25 · Cited by 3
Metadata
- Authors
- Yang, J., Guo, F., Chin, H. S., Chen, G. B., Zhang, Z., Williams, L., Kueh, A. J., Chow, P. K. H., Herold, M. J., & Fu, N. Y.
- Affiliations
- The University of Melbourne (AU)
- Duke-NUS Medical School (SG)
- National Cancer Centre Singapore (SG)
- National University of Singapore (SG)
- Corresponding author
- Fu, Nai Yang
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2025-07-29
- Volume
- 14
- Issue
- 15
- Pages
- 1165
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC12346671
- OpenAlex
- W4412895970
- Cited by
- 1
- References
- 33
- Citations by year
- 2026: 1
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Gilead Research Scholars Liver Disease Program (Asia) (2020-Gilead-001, MOH-000614, MCRF22013, 2037907, MOH-000546)
- NMRC OF-IRG (2020-Gilead-001, MOH-000614, MCRF22013, 2037907, MOH-000546)
- Khoo Bridge Funding Awards (2020-Gilead-001, MOH-000614, MCRF22013, 2037907, MOH-000546)
- Victorian Cancer Agency Mid-Career Research Fellowship (2020-Gilead-001, MOH-000614, MCRF22013, 2037907, MOH-000546)
- NHMRC 2024 Ideas (2020-Gilead-001, MOH-000614, MCRF22013, 2037907, MOH-000546)
- NMRC OF-YIRG (2020-Gilead-001, MOH-000614, MCRF22013, 2037907, MOH-000546)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9 genome editing, random integration, electroporation, CRISPR screen, transcriptional regulation
- MeSH terms
- Gene Editing, Genetic Vectors, Homozygote, Humans, Lentivirus, Genes, Reporter, Gene Knock-In Techniques, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.